Immatics (IMTX) Short-Term Debt repayments (2022 - 2025)

Immatics recorded quarterly Short-Term Debt repayments of -$870704.5 in Q4 2025, down 0.92% quarter-over-quarter from -$862762.7 in Q3 2025, and down 3.93% year-over-year from -$906324.2 in Q4 2024.

Immatics' Short-Term Debt repayments history runs 4 years deep, the most recent figure standing at -$870704.5 for Q4 2025.

  • In Q4 2025, Short-Term Debt repayments fell 3.93% year-over-year to -$870704.5; the TTM figure through Dec 2025 stood at -$3.5 million (down 1549.35% YoY), while the FY2025 annual figure was -$3.3 million, down 55.49% from the prior year.
  • Short-Term Debt repayments came in at -$870704.5 for Q4 2025 at Immatics, down from -$862762.7 in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $3.1 million in Q4 2023 to a low of -$1.1 million in Q3 2023.
  • A 4-year average of -$542186.7 and a median of -$850270.7 in 2024 frame the typical range for Short-Term Debt repayments.
  • Across the five-year window, Short-Term Debt repayments soared 544.93% in 2023 and slumped 127.1% in 2024, its largest moves.
  • Immatics' Short-Term Debt repayments stood at -$694788.5 in 2022, then soared by 544.93% to $3.1 million in 2023, then slumped by 127.1% to -$837778.8 in 2024, then retreated by 3.93% to -$870704.5 in 2025.
  • According to Business Quant data, Short-Term Debt repayments over the past three periods registered -$870704.5, -$862762.7, and -$837778.8 for Q4 2025, Q3 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 102,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Immatics 1.80 Bn 1.80 Bn - -870,704.55

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -870,704.55
Dec 31, 2025 -870,704.55
Sep 30, 2025 -862,762.66
Sep 30, 2025 -862,762.66
Dec 31, 2024 -837,778.79
Dec 31, 2024 -837,778.79
Sep 30, 2024 -912,620.41
Sep 30, 2024 -912,620.41
Dec 31, 2023 3.09 Mn
Dec 31, 2023 3.09 Mn
Sep 30, 2023 -1.10 Mn
Sep 30, 2023 -1.10 Mn
Jun 30, 2023 -1.09 Mn
Jun 30, 2023 -1.09 Mn
Mar 31, 2023 -929,514.02
Mar 31, 2023 -929,514.02
Dec 31, 2022 -694,788.46
Dec 31, 2022 -694,788.46
Sep 30, 2022 -774,354.69
Sep 30, 2022 -774,354.69
Jun 30, 2022 -752,274.97
Jun 30, 2022 -752,274.97
Mar 31, 2022 -773,290.69
Mar 31, 2022 -773,290.69